Evaluation of two models of delivering anticoagulant care to house bound patients in the community: a multidisciplinary study
| ISRCTN | ISRCTN24180077 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN24180077 |
| Protocol serial number | N0205114493 |
| Sponsor | Department of Health (UK) |
| Funder | Barts and The London NHS Trust (UK) |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 13/10/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Haematological Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Dita Engova
Scientific
Scientific
Department of Pharmacy
Homerton University Hospital
Homerton Row
London
E9 6SR
United Kingdom
| Phone | +44 (0)20 8510 7002 |
|---|---|
| engovad@lsbu.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Evaluation of two models of delivering anticoagulant care to house bound patients in the community: a multidisciplinary study |
| Study objectives | We aim to evaluate two models of delivering anticoagulant care to house-bound patients in the community. The study will evaluate the proposed models in terms of patients clinical outcome, patient and professional satisfaction and health economics, and compare them with the traditional hospital-based model. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Anticoagulation therapy |
| Intervention | Randomised controlled crossover study. Two models of outreach anticoagulation service will be compared with the traditional hospital based model. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | warfarin |
| Primary outcome measure(s) |
1. Clinical: |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 31/03/2004 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 200 |
| Key inclusion criteria | The approximately 200 patients presently anticoagulated with warfarin at Barts and The London NHS Trust anticoagulation clinic with mobility impairment will be invited to participate and consenters randomly assigned to one of the two anticoagulation service provision schemes, i.e. model A followed by model B, or model B followed by model A. |
| Key exclusion criteria | Does not match inclusion criteria |
| Date of first enrolment | 01/10/2002 |
| Date of final enrolment | 31/03/2004 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Department of Pharmacy
London
E9 6SR
United Kingdom
E9 6SR
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
13/10/2017: No publications found in PubMed, verifying study status with principal investigator.